XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2021     34,333          
Beginning Balance at Dec. 31, 2021 $ 1,583,321 $ (12,053) $ 343 $ 13,662 $ (34,131) $ 1,698,156 $ 22,078 $ (128,840)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 59,321         59,321    
Other comprehensive income (loss)                
Cumulative translation adjustment (6,191)             (6,191)
Issuance of common stock in connection with:                
Exercise of options (in shares)     26          
Exercise of options 923     923        
Restricted share grants, less net settled shares (in shares)     134          
Restricted share grants, less net settled shares (7,834)   $ 2 (7,836)        
Stock units issued under incentive compensation plan 1,664     1,664        
Purchase and retirement of common stock (in shares)     (22)          
Purchase and retirement of common stock (3,098)     (3,098)        
Conversion of convertible senior notes due 2023 (2)     (2)        
Share-based compensation 5,967     5,967        
Reclassification of negative additional paid-in capital 0     22,851   (22,851)    
Ending Balance (in shares) at Mar. 31, 2022     34,471          
Ending Balance at Mar. 31, 2022 1,622,018   $ 345 0   1,756,704   (135,031)
Beginning Balance (in shares) at Dec. 31, 2021     34,333          
Beginning Balance at Dec. 31, 2021 1,583,321 $ (12,053) $ 343 13,662 $ (34,131) 1,698,156 $ 22,078 (128,840)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 188,016              
Issuance of common stock in connection with:                
Stock units issued under incentive compensation plan 1,664              
Ending Balance (in shares) at Sep. 30, 2022     34,422          
Ending Balance at Sep. 30, 2022 1,644,583   $ 344 0   1,868,424   (224,185)
Beginning Balance (in shares) at Mar. 31, 2022     34,471          
Beginning Balance at Mar. 31, 2022 1,622,018   $ 345 0   1,756,704   (135,031)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 51,428         51,428    
Other comprehensive income (loss)                
Cumulative translation adjustment (40,679)             (40,679)
Issuance of common stock in connection with:                
Exercise of options (in shares)     22          
Exercise of options 687     687        
Restricted share grants, less net settled shares (in shares)     47          
Restricted share grants, less net settled shares (8,907)     (8,907)        
Conversion of convertible senior notes due 2023 (11)     (11)        
Share-based compensation 6,083     6,083        
Reclassification of negative additional paid-in capital 0     2,647   (2,647)    
Ending Balance (in shares) at Jun. 30, 2022     34,540          
Ending Balance at Jun. 30, 2022 1,630,619   $ 345 499   1,805,485   (175,710)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 77,267         77,267    
Other comprehensive income (loss)                
Cumulative translation adjustment (48,475)             (48,475)
Issuance of common stock in connection with:                
Restricted share grants, less net settled shares (in shares)     10          
Restricted share grants, less net settled shares (837)     (837)        
Purchase and retirement of common stock (in shares)     (128)          
Purchase and retirement of common stock (20,432)   $ (1) (20,431)        
Share-based compensation 6,441     6,441        
Reclassification of negative additional paid-in capital 0     14,328   (14,328)    
Ending Balance (in shares) at Sep. 30, 2022     34,422          
Ending Balance at Sep. 30, 2022 $ 1,644,583   $ 344 0   1,868,424   (224,185)
Beginning Balance (in shares) at Dec. 31, 2022 34,026   34,026          
Beginning Balance at Dec. 31, 2022 $ 1,681,721   $ 340 0   1,858,103   (176,722)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 47,547         47,547    
Other comprehensive income (loss)                
Cumulative translation adjustment 9,850             9,850
Issuance of common stock in connection with:                
Exercise of options (in shares)     14          
Exercise of options 449     449        
Restricted share grants, less net settled shares (in shares)     55          
Restricted share grants, less net settled shares (9,513)   $ 1 (9,514)        
Stock units issued under incentive compensation plan 2,274     2,274        
Purchase and retirement of common stock (in shares)     (112)          
Purchase and retirement of common stock (17,799)   $ (1) (17,798)        
Conversion of convertible senior notes due 2023 (6)     (6)        
Share-based compensation 6,365     6,365        
Reclassification of negative additional paid-in capital 0     18,230   (18,230)    
Ending Balance (in shares) at Mar. 31, 2023     33,983          
Ending Balance at Mar. 31, 2023 $ 1,720,888   $ 340 0   1,887,420   (166,872)
Beginning Balance (in shares) at Dec. 31, 2022 34,026   34,026          
Beginning Balance at Dec. 31, 2022 $ 1,681,721   $ 340 0   1,858,103   (176,722)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 193,259              
Issuance of common stock in connection with:                
Stock units issued under incentive compensation plan $ 2,274              
Ending Balance (in shares) at Sep. 30, 2023 35,510   35,510          
Ending Balance at Sep. 30, 2023 $ 1,864,495   $ 355 9,712   2,033,132   (178,704)
Beginning Balance (in shares) at Mar. 31, 2023     33,983          
Beginning Balance at Mar. 31, 2023 1,720,888   $ 340 0   1,887,420   (166,872)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 62,395         62,395    
Other comprehensive income (loss)                
Cumulative translation adjustment 6,396             6,396
Issuance of common stock in connection with:                
Exercise of options (in shares)     21          
Exercise of options 718     718        
Restricted share grants, less net settled shares (in shares)     30          
Restricted share grants, less net settled shares (2,408)     (2,408)        
Conversion of convertible senior notes due 2023 (375)     (375)        
Share-based compensation 7,538     7,538        
Ending Balance (in shares) at Jun. 30, 2023     34,034          
Ending Balance at Jun. 30, 2023 1,795,152   $ 340 5,473   1,949,815   (160,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 83,317         83,317    
Other comprehensive income (loss)                
Cumulative translation adjustment (18,228)             (18,228)
Issuance of common stock in connection with:                
Exercise of options (in shares)     1          
Exercise of options 42     42        
Restricted share grants, less net settled shares (in shares)     14          
Restricted share grants, less net settled shares (3,291)     (3,291)        
Settlement of conversion premium of convertible senior notes due 2023 (in shares)     1,461          
Settlement of conversion premium of convertible senior notes due 2023 (6)   $ 15 (21)        
Share-based compensation $ 7,509     7,509        
Ending Balance (in shares) at Sep. 30, 2023 35,510   35,510          
Ending Balance at Sep. 30, 2023 $ 1,864,495   $ 355 $ 9,712   $ 2,033,132   $ (178,704)